Clareo Health | Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or Bilateral Sensorineural Hearing Loss.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pediatrix
The purpose of this study is to determine the true incidence of long QT (LQT) amongst a large cohort of subjects diagnosed with unilateral (right/left) or bilateral sensorineural hearing loss.
The goal of this study is to answer the following questions:
1. What is the incidence of an abnormal ECG (QTc \> 450 msec) in neonates greater than a week of age with either unilateral or bilateral Sensorineural hearing loss?
2. What percentage of neonates greater than one week of age with either bilateral or unilateral sensorineural hearing loss and an abnormal ECG have an identifiable genetic mutation?
3. What is the incidence of an abnormal genetic mutation consistent with long QT regardless of the ECG in neonates with bilateral sensorineural hearing loss?
Age
0–0
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
All newborns who demonstrate a refer in one or both ears on a routine newborn hearing screen
Documentation of informed consent
Inborn
Ability to perform an ABR (auditory brainstem response screen technology) screening test
No major anomalies
Subjects' parents willing to provide follow-up data on their child
You may not be if
Newborns with a syndromic cause of hearing loss
Parents unwilling to provide follow-up data
Major congenital anomalies
Major medical problem or conditions. (i.e., hypoxic ischemic encephalopathy (HIE), persistent pulmonary hypertension neonate (PPHN), meconium aspiration, etc.)
